We here investigate the crosstalk of PKC and PKA signalling during primary CD3 + T lymphocyte activation using pharmacological inhibitors and activators in combination with our 
IL-2 production, however, complete abrogation of IL-2 production in these PKCθ -/-T cells was only achieved by simultaneous co-activation of the cAMP/PKA pathway in CD3 + T cells.
Conversely, the reduced IL-2 production in PKC inhibitor treated T cells can be rescued by For personal use only. on . by guest www.bloodjournal.org Following T cell receptor (TCR) stimulation, lymphocyte activation threshold is coordinated by a complex interplay of distinct signal transductions pathways. The "fine-tuning" of signalling cascades is considered as a crucial step during T cell activation in order to result in adequate amplitude of an immune response. The molecular processes that regulate the precise level of immune activation and their complex inter-pathway integration are, however, still poorly understood. Among several signalling pathways, Protein kinase C (PKC) plays an important role in the cellular activation pathway downstream of the antigen receptor. PKCθ, in particular, is known to translocate to the immunological synapse 1 . Once activated, PKCθ plays a critical role in TCR signalling 2 . This is confirmed by analysis of CD3 + T cells of mice lacking PKCθ.
Ex vivo, PKCθ-deficient T cells are mostly TCR-unresponsive and deficient in the production of interleukin 2 (IL-2) due to an impaired transactivation of NF-κB, AP-1 and NF-AT [3] [4] [5] . In strict contrast, the cyclic adenosine monophosphate (cAMP) dependent protein kinase A (PKA) pathway represents a negative regulatory mechanism that controls IL-2 expression in T cells.
cAMP itself has been demonstrated to activate directly a class of cyclic nucleotide ion channels 6, 7 as well as the Rap1 guanine exchange factors Epac1 and Epac2 8 . The principle cAMP receptor in lymphoid cells, however, is PKA 9 .
cAMP is produced after TCR stimulation in T lymphocytes, suggesting the cAMP-mediated repression of T cell activation may represent a physiological negative feedback control mechanism 10 . Suppression of cAMP signalling is thus required for T-cell activation 11 . Among other mechanisms, cAMP inhibition is mediated by de-novo transcriptional induction of phosphodiesterases (PDEs) upon T cell activation. In T cells, PDE4 seems to play a particularly important role 12, 13 . Increased PDE4 expression in T cells is associated with increased IL-2 production via its hydrolysis of cAMP 12 . Inversely, PDE4 blockade is shown to augment cAMP levels and thus known to abrogate cytokine secretion and proliferation in T cells through inhibition of NF-κB and NF-AT and activation of CREB 13 . Several direct targets of cAMP/PKA signalling have been identified, such as CREB 14 , COOH-terminal Src kinase (Csk) 15 and NF-AT 16 . The detailed interplay and potential crosstalks of PKA with other signalling pathways during physiological T cell activation, however, remain mostly unresolved.
Employing cell-permanent pharmacological inhibitors and activators of PKA and PKC, a All experiments have been performed at least three times with similar outcomes.
Gel Mobility Shift Assays
Nuclear extracts were harvested from 2x10 7 cells according to standard protocols as previously 
Statistical analysis
Statistical analysis was done with the statistic environment R (www.cran.r-project.org) as described by 25, 26 .
RESULTS:
Activation of resting T lymphocytes (resulting in IL-2 cytokine secretion and subsequent proliferation) is known to require stimulation of the TCR/CD3 complex (plus the CD28 auxiliary receptor) or treatment with phorbol ester (a potent PKC agonist) plus Ca 2+ ionophore.
In this study we investigated potential crosstalk between the distinct second messenger systems, DAG and cAMP, with regard to the activation of CD3 + T lymphocytes in vitro. Figure 
org From
Consistently, the effect of the panPKC LMWI was significantly rescued by an PKA inhibitor 
DISCUSSION
On the basis of pleiotropic pharmacological inhibition studies, several examples of crosstalk between the cAMP/PKA and PKC pathways are described [32] [33] [34] . It appears strictly cell-type dependent, whether the crosstalk between PKA and PKC thereby counteracted or potentiate each other: In platelets and neutrophils, the PKC pathway activates cellular functions, such as In primary T lymphocytes, however, cAMP is produced after stimulation, suggesting the cAMP-mediated repression of T cell activation following TCR/CD3 ligation represents a negative feedback control mechanism 10 . Consequently, suppression of cAMP signalling is strictly required for a biological T-cell response 11 . cAMP levels in the T cell are the results of adenylate cyclases which synthezise cAMP and phosphodiesterases (PDEs) that degrade cAMP.
The PDE4 isotype thereby mainly controls cAMP levels during T cell activation 13 .
The most intriguing result of our study is, that during TCR activation of primary CD3 + T cells, thereby is known to induce Csk activation 35 , the major negative regulator of the Src-PTK Lck 15 . Additionally, PKA has been reported to directly phosphorylate NF-AT and thus inhibits nuclear entry of NF-AT via association with 14-3-3 proteins 16 . Consistently, overexpression of 14 rate-limiting steps in triggering a full T cell IL-2 production during antigenic stimulation. Full and sustained NF-AT must be maintained to induce an irreversible commitment to T cell activation, particularly at lower antigenic peptide concentrations. Along this line of argumentation, PKCθ-deficient T cells generate still detectable, albeit significantly reduced nuclear localization of NF-ATc family members (Figure 8 C) . Given the importance of the sustained NF-AT translocation, this partial reduction appears to correlate with an inability of the stimulus to induce full IL-2 gene expression and T cell proliferation in these T cells 4 .
Consistently, agents that raise PKA activity in T cells, such as PDE4 LMWI and Sp cAMP counteract PKCθ activation signalling by this mechanism (Figure 2 & 6 ). Given that upstream regulatory regions of many genes contain NF-AT binding sites 42 , the described PKCθ and PKA inter-pathway integration may modulate a number of genes during an effective immune response. In deed, other cytokines, in particular IL-4 and IL-10, were found to be inhibited by
PKA activation in these T cells (data not shown). This is consistent with recent reports that
PKCθ is required for the development of a robust immune response controlled by TH2 cells 43 .
Even so the antagonistic roles of PKA and PKCθ dependent signalling cascades are here defined, the exact biochemical mechanism of how positive PKCθ and the negative PKA signalling pathways regulate the fine-tuning of the critical NF-AT responses, however, is still speculative.
Conclusion:
In Experiments were repeated at least three times with similar results. 
